Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.82B | 23.47B | 20.81B | 18.03B | 15.77B | 18.58B |
Gross Profit | 6.46B | 6.57B | 5.25B | 4.08B | 3.49B | 3.66B |
EBITDA | 3.01B | 3.14B | 2.20B | 1.20B | 925.49M | 1.03B |
Net Income | 1.95B | 1.97B | 1.30B | 540.62M | 364.44M | 442.49M |
Balance Sheet | ||||||
Total Assets | 19.06B | 17.94B | 18.62B | 15.11B | 13.32B | 13.97B |
Cash, Cash Equivalents and Short-Term Investments | 2.37B | 2.27B | 2.10B | 1.42B | 1.24B | 1.72B |
Total Debt | 2.05B | 1.91B | 2.15B | 2.21B | 1.84B | 2.13B |
Total Liabilities | 10.89B | 9.32B | 11.63B | 9.35B | 8.02B | 8.95B |
Stockholders Equity | 8.18B | 8.63B | 7.00B | 5.77B | 5.30B | 5.03B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 745.13M | 884.57M | 13.20M | -119.96M | 717.27M |
Operating Cash Flow | 0.00 | 1.32B | 1.31B | 260.11M | 333.90M | 1.01B |
Investing Cash Flow | 0.00 | -511.12M | -411.44M | -329.88M | -409.55M | -71.63M |
Financing Cash Flow | 0.00 | -645.20M | -223.57M | 245.57M | -414.26M | -576.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥12.98B | 5.39 | 4.34% | 15.66% | 38.65% | ||
77 Outperform | ¥19.58B | 9.08 | 3.14% | 12.80% | 51.15% | ||
70 Outperform | ¥175.46B | 11.07 | 6.29% | 3.46% | 3.91% | 3.49% | |
69 Neutral | ¥8.18B | 19.87 | 2.25% | 2.12% | 21.91% | ||
67 Neutral | ¥2.41B | 6.80 | 0.37% | 8.63% | 328.33% | ||
55 Neutral | ¥3.03B | 8.35 | 4.27% | -4.41% | -39.78% | ||
42 Neutral | ¥16.27B | 98.19 | 4.48% | -1.86% | -134.14% |